Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $129.72 USD
Change Today +0.81 / 0.63%
Volume 244.3K
TFX On Other Exchanges
New York
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/22/15 - $130.25
52 Week Low
10/15/14 - $101.95
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. The company also provides respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand. In addition, it offers surgical products, such as ligation clips and closure products; appliers and sutures used in surgical procedures; access ports for use in minimally invasive laparoscopic surgical procedures; robotic surgery and fluid management products for use in chest drainage; and reusable hand-held instruments for surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. Further, the company offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; specialized catheters; therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Additionally, it provides catheters, urine collectors, catheterization accessories, and products for operative endourology under the Rusch brand name; micro-laparoscopic instrumentation products; and original equipment manufacturing services. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,700 Employees
Last Reported Date: 02/20/15
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $866.7K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $468.6K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $431.5K
Senior Vice President of Global Operations
Total Annual Compensation: $312.2K
Vice President of Global Human Resources
Total Annual Compensation: $281.8K
Compensation as of Fiscal Year 2014.

teleflex inc (TFX) Key Developments

Teleflex Incorporated - Analyst/Investor Day

Teleflex Incorporated - Analyst/Investor Day

Teleflex Incorporated Declares Quarterly Cash Dividend Payable on June 15, 2015

Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable June 15, 2015 to shareholders of record at the close of business on May 14, 2015.

Teleflex Incorporated Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 29, 2015; Provides Earnings Guidance for the Year 2015

Teleflex Incorporated reported unaudited consolidated earnings results for the first quarter ended March 29, 2015. For the quarter, the company's net revenues were $429,430,000 against $438,546,000 a year ago. Income from continuing operations before interest and taxes was $65,608,000 against $59,020,000 a year ago. Income from continuing operations before taxes was $48,605,000 against $43,803,000 a year ago. Income from continuing operations was $39,273,000 or $0.83 diluted per share against $35,269,000 or $0.77 diluted per share a year ago. Net income was $38,570,000 against $35,144,000 a year ago. Net income attributable to common shareholders was $38,352,000 or $0.81 diluted per share against $34,958,000 or $0.76 diluted per share a year ago. Net cash provided by operating activities from continuing operations was $42,358,000 against $41,918,000 a year ago. Expenditures for property, plant and equipment was $14,445,000 against $12,109,000 a year ago. Adjusted net income attributable to common shareholders was $57.3 million or $1.30 diluted per share against $53.0 million or $1.22 diluted per share a year ago. Net debt obligations at march 29, 2015 were $825.8 million compared to $801.4 million at December 31, 2014. The company continues to estimate that constant currency revenue growth will be between 4% and 6%. on a GAAP basis, revenues are expected to be flat to down 2% versus the prior year due to the unfavorable impact of foreign currency fluctuations. The company also continues to estimate that adjusted diluted earnings per share from continuing operations will be between $6.10 and $6.35, representing an increase of 6.3% to 10.6% over the prior year. Previously, the company expected foreign currency fluctuations to negatively impact adjusted earnings per share in 2015 by approximately 14%. Current expectation reflects that foreign currency fluctuations will negatively impact adjusted earnings per share in 2015 by approximately 15%. the company has updated its full year 2015 GAAP diluted earnings per share from continuing operations range from $4.22 to $4.37 to a range of $4.13 to $4.28.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $129.72 USD +0.81

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Donaldson Co Inc $36.41 USD -0.01
IDEXX Laboratories Inc $138.72 USD +0.69
PerkinElmer Inc $53.39 USD 0.00
Sirona Dental Systems Inc $98.49 USD +0.20
STERIS Corp $69.13 USD -0.51
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 31.3x
Price/Sales 3.0x
Price/Book 2.9x
Price/Cash Flow 28.2x
TEV/Sales 2.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at